Metraipolis › archive › dc_7fb87e2f6bf5

Deep-Learning Algorithm for Indeterminate Thyroid Nodules: Comparison and Combination with Molecular Testing — arXiv:2611.05400

Source
arXiv (en)
Original
https://arxiv.org/abs/2611.05400
License (as archived)
CC0-1.0
Archived
2026-11-05T18:35:36.496Z
SHA-256 of the archived text
5d801023a2757bd08d86f771cee384c521d3cc0ab922c00d39a1e32bab9062d4
Stable URL of this page
https://metraipolis.com/documento/dc_7fb87e2f6bf5

How to cite

Deep-Learning Algorithm for Indeterminate Thyroid Nodules: Comparison and Combination with Molecular Testing — arXiv:2611.05400 — arXiv (en), https://arxiv.org/abs/2611.05400 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_7fb87e2f6bf5 (Metraipolis archive dc_7fb87e2f6bf5, sha256 5d801023a2757bd08d86f771cee384c521d3cc0ab922c00d39a1e32bab9062d4)
BibTeX
@misc{dc7fb87e2f6bf5,
  title = {Deep-Learning Algorithm for Indeterminate Thyroid Nodules: Comparison and Combination with Molecular Testing — arXiv:2611.05400},
  howpublished = {arXiv (en)},
  url = {https://arxiv.org/abs/2611.05400},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_7fb87e2f6bf5; sha256 5d801023a2757bd08d86f771cee384c521d3cc0ab922c00d39a1e32bab9062d4},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: arXiv (en), https://arxiv.org/abs/2611.05400. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Thyroid nodules with indeterminate cytology (Bethesda III) carry an intermediate risk of malignancy, and molecular testing is widely used to decide between surgery and surveillance, but it is costly and not universally available. We investigated whether a convolutional neural network (CNN) applied to routine ultrasound images can stratify Bethesda III nodules, and how it compares and combines with molecular testing. We retrospectively identified 466 nodule records from 418 patients who underwent molecular testing (Afirma or ThyroSeq). A CNN pre-trained on determinate nodules was adapted to indeterminate nodules with soft labels and transfer learning. After removal of duplicate records, 119 nodules with surgical pathology were used for development and 47 were held out for testing. On the test set, the deep learning (DL) model achieved an AUC of 0.73 (95% CI 0.51-0.94), compared with 0.55 (0.38-0.71) for molecular testing (P = 0.15). At a cut-off inherited from the original algorithm, the DL model was more specific than molecular testing (0.95 vs 0.32; P < 0.001), with a higher positive predictive value (0.67 vs 0.21), a lower sensitivity (0.44 vs 0.78; P = 0.25) and a similar negative predictive value (0.88 vs 0.86). All six DL-positive test nodules were molecular-positive, and the DL output split the molecular-positive nodules into a high-risk (4/6 malignant) and a lower-risk group (3/27 malignant; P = 0.01). Surgical verification was strongly driven by the molecular result (99% of positive vs 19% of negative results), and molecular-test accuracy depended on the platform. A logistic regression of the DL output, nodule size and the molecular result dropped the DL term and did not improve on the DL output alone. Ultrasound DL complemented molecular testing for Bethesda III nodules, in particular by identifying molecular-positive nodules at lower risk of malignancy.

Tema degli esploratori: scienze della vita e salute (elenco arXiv q-bio.QM, nuovi lavori del giorno).
Categorie arXiv: Quantitative Methods (q-bio.QM) ; Image and Video Processing (eess.IV).
Pagina del lavoro: https://arxiv.org/abs/2611.05400 — autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza: titolo e abstract sono metadati arXiv distribuiti in CC0 1.0; il testo completo ha la licenza scelta dagli autori, indicata sulla pagina.
Letto il 2026-11-05T18:29:46.595Z dalla pagina https://arxiv.org/list/q-bio.QM/new (consentita dal robots.txt di arxiv.org, con il suo crawl-delay).